Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hysterectomy | 47 | 2022 | 927 | 10.380 |
Why?
|
Laparoscopy | 77 | 2023 | 2121 | 9.760 |
Why?
|
Gynecologic Surgical Procedures | 19 | 2020 | 336 | 5.590 |
Why?
|
Leiomyoma | 23 | 2023 | 728 | 4.430 |
Why?
|
Uterine Neoplasms | 26 | 2023 | 1513 | 3.600 |
Why?
|
Robotics | 15 | 2014 | 892 | 3.150 |
Why?
|
Uterine Diseases | 9 | 2017 | 135 | 2.660 |
Why?
|
Suture Techniques | 13 | 2020 | 797 | 2.610 |
Why?
|
Endometriosis | 11 | 2023 | 834 | 2.530 |
Why?
|
Cerclage, Cervical | 8 | 2023 | 39 | 2.410 |
Why?
|
Sutures | 7 | 2020 | 298 | 2.250 |
Why?
|
Hysterectomy, Vaginal | 7 | 2019 | 37 | 2.230 |
Why?
|
Pelvic Organ Prolapse | 6 | 2020 | 134 | 2.100 |
Why?
|
Uterine Cervical Incompetence | 5 | 2023 | 29 | 2.080 |
Why?
|
Blood Loss, Surgical | 14 | 2019 | 656 | 2.010 |
Why?
|
Sterilization, Tubal | 5 | 2020 | 87 | 1.600 |
Why?
|
Hysteroscopy | 5 | 2020 | 102 | 1.410 |
Why?
|
Vasopressins | 3 | 2017 | 370 | 1.310 |
Why?
|
Vagina | 9 | 2022 | 825 | 1.240 |
Why?
|
Cervix Uteri | 13 | 2023 | 591 | 1.190 |
Why?
|
Tissue Adhesions | 4 | 2019 | 235 | 1.150 |
Why?
|
Intraoperative Complications | 6 | 2017 | 1188 | 1.100 |
Why?
|
Hemostatics | 3 | 2016 | 229 | 1.030 |
Why?
|
Cystoscopy | 2 | 2016 | 134 | 0.970 |
Why?
|
Gynecology | 5 | 2018 | 509 | 0.970 |
Why?
|
Postoperative Complications | 21 | 2020 | 15244 | 0.840 |
Why?
|
Myometrium | 2 | 2014 | 181 | 0.830 |
Why?
|
Fistula | 2 | 2022 | 218 | 0.820 |
Why?
|
Pelvic Pain | 4 | 2023 | 273 | 0.810 |
Why?
|
Salpingectomy | 3 | 2017 | 52 | 0.810 |
Why?
|
Hospital Costs | 3 | 2012 | 980 | 0.780 |
Why?
|
Surgical Mesh | 2 | 2013 | 256 | 0.750 |
Why?
|
Urologic Surgical Procedures | 2 | 2016 | 301 | 0.750 |
Why?
|
Female | 113 | 2023 | 379592 | 0.710 |
Why?
|
Clinical Competence | 7 | 2018 | 4681 | 0.690 |
Why?
|
Surgical Instruments | 3 | 2017 | 394 | 0.690 |
Why?
|
Sterilization Reversal | 1 | 2019 | 5 | 0.690 |
Why?
|
Pregnancy, Ectopic | 2 | 2014 | 141 | 0.670 |
Why?
|
Genital Diseases, Female | 2 | 2012 | 197 | 0.650 |
Why?
|
Peritoneal Diseases | 1 | 2019 | 75 | 0.640 |
Why?
|
Device Removal | 3 | 2019 | 652 | 0.610 |
Why?
|
Educational Measurement | 3 | 2018 | 1206 | 0.600 |
Why?
|
Ureteral Diseases | 1 | 2016 | 61 | 0.580 |
Why?
|
Adnexal Diseases | 1 | 2017 | 102 | 0.560 |
Why?
|
Urinary Bladder Diseases | 1 | 2016 | 166 | 0.540 |
Why?
|
Models, Anatomic | 2 | 2017 | 690 | 0.540 |
Why?
|
Hemostasis, Surgical | 1 | 2016 | 128 | 0.540 |
Why?
|
Intrauterine Devices | 1 | 2017 | 122 | 0.530 |
Why?
|
Endometrial Ablation Techniques | 1 | 2015 | 11 | 0.520 |
Why?
|
Specimen Handling | 3 | 2015 | 692 | 0.520 |
Why?
|
Obstetrics | 3 | 2018 | 657 | 0.520 |
Why?
|
Hospitals, University | 3 | 2018 | 571 | 0.490 |
Why?
|
Adult | 58 | 2023 | 213712 | 0.490 |
Why?
|
Humans | 113 | 2023 | 742088 | 0.480 |
Why?
|
Retrospective Studies | 35 | 2023 | 77098 | 0.480 |
Why?
|
Laparotomy | 7 | 2020 | 474 | 0.460 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2013 | 16 | 0.450 |
Why?
|
Uterine Cervical Diseases | 1 | 2013 | 77 | 0.450 |
Why?
|
Catheters | 1 | 2016 | 422 | 0.440 |
Why?
|
Coloring Agents | 1 | 2015 | 565 | 0.440 |
Why?
|
Surgery Department, Hospital | 1 | 2014 | 175 | 0.440 |
Why?
|
Urinary Tract | 1 | 2016 | 308 | 0.430 |
Why?
|
Treatment Outcome | 29 | 2023 | 62966 | 0.430 |
Why?
|
Head-Down Tilt | 1 | 2012 | 64 | 0.430 |
Why?
|
Middle Aged | 47 | 2023 | 213127 | 0.420 |
Why?
|
Intestinal Diseases | 1 | 2017 | 531 | 0.420 |
Why?
|
Education, Medical, Graduate | 3 | 2019 | 2283 | 0.390 |
Why?
|
Pregnancy | 20 | 2023 | 29087 | 0.390 |
Why?
|
Tongue | 1 | 2014 | 406 | 0.390 |
Why?
|
Perioperative Period | 2 | 2018 | 256 | 0.380 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2010 | 60 | 0.380 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2012 | 118 | 0.370 |
Why?
|
Ileal Diseases | 1 | 2010 | 74 | 0.360 |
Why?
|
Colpotomy | 2 | 2020 | 14 | 0.360 |
Why?
|
Internship and Residency | 5 | 2019 | 5774 | 0.360 |
Why?
|
Cystocele | 1 | 2009 | 5 | 0.350 |
Why?
|
Patient Positioning | 1 | 2012 | 322 | 0.350 |
Why?
|
Cicatrix | 1 | 2014 | 761 | 0.330 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1203 | 0.310 |
Why?
|
Premature Birth | 5 | 2023 | 1713 | 0.310 |
Why?
|
Anesthetics, Local | 2 | 2005 | 984 | 0.310 |
Why?
|
Abdomen | 4 | 2022 | 1107 | 0.310 |
Why?
|
Uterus | 2 | 2014 | 710 | 0.310 |
Why?
|
Scopolamine | 1 | 2008 | 99 | 0.300 |
Why?
|
Uterine Rupture | 2 | 2022 | 72 | 0.300 |
Why?
|
Cesarean Section | 2 | 2022 | 1363 | 0.300 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2008 | 118 | 0.300 |
Why?
|
Education, Medical, Continuing | 2 | 2015 | 839 | 0.290 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 424 | 0.280 |
Why?
|
Platelet-Rich Plasma | 1 | 2009 | 177 | 0.280 |
Why?
|
Antiemetics | 1 | 2008 | 176 | 0.280 |
Why?
|
Benzocaine | 1 | 2005 | 15 | 0.270 |
Why?
|
Pain, Postoperative | 3 | 2021 | 1638 | 0.270 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4029 | 0.270 |
Why?
|
Infertility | 2 | 2021 | 655 | 0.250 |
Why?
|
Patient Readmission | 2 | 2019 | 3111 | 0.250 |
Why?
|
Intestine, Small | 1 | 2010 | 1243 | 0.240 |
Why?
|
Pregnancy Outcome | 3 | 2022 | 2795 | 0.240 |
Why?
|
Boston | 8 | 2019 | 9305 | 0.240 |
Why?
|
Cohort Studies | 13 | 2023 | 40450 | 0.230 |
Why?
|
Cost of Illness | 1 | 2012 | 1852 | 0.220 |
Why?
|
Surgical Procedures, Operative | 1 | 2014 | 1873 | 0.210 |
Why?
|
Endometrium | 1 | 2005 | 424 | 0.210 |
Why?
|
General Surgery | 2 | 2004 | 1633 | 0.210 |
Why?
|
Quality of Life | 6 | 2021 | 12730 | 0.210 |
Why?
|
Wound Healing | 2 | 2012 | 2781 | 0.200 |
Why?
|
Hypogastric Plexus | 1 | 2021 | 10 | 0.200 |
Why?
|
Teratoma | 1 | 2004 | 387 | 0.200 |
Why?
|
Bupivacaine | 1 | 2004 | 408 | 0.200 |
Why?
|
Tumor Burden | 2 | 2018 | 1905 | 0.200 |
Why?
|
Length of Stay | 6 | 2019 | 6294 | 0.190 |
Why?
|
Obstetric Labor, Premature | 2 | 2013 | 279 | 0.190 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39004 | 0.190 |
Why?
|
Reproductive Medicine | 1 | 2022 | 108 | 0.180 |
Why?
|
Endoscopy | 2 | 2017 | 1774 | 0.180 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1640 | 0.180 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3391 | 0.170 |
Why?
|
Uterine Hemorrhage | 2 | 2015 | 255 | 0.170 |
Why?
|
Sheep | 2 | 2012 | 1437 | 0.170 |
Why?
|
Spermatozoa | 1 | 2003 | 625 | 0.170 |
Why?
|
Fellowships and Scholarships | 2 | 2022 | 1066 | 0.170 |
Why?
|
Sexual Partners | 1 | 2003 | 730 | 0.160 |
Why?
|
United States | 13 | 2021 | 69693 | 0.160 |
Why?
|
Professional Competence | 1 | 2002 | 448 | 0.160 |
Why?
|
Leiomyosarcoma | 1 | 2023 | 477 | 0.160 |
Why?
|
Perioperative Care | 2 | 2019 | 997 | 0.160 |
Why?
|
Single-Blind Method | 2 | 2012 | 1589 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11695 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.160 |
Why?
|
Peritoneum | 1 | 2019 | 226 | 0.150 |
Why?
|
Aged | 12 | 2022 | 162944 | 0.150 |
Why?
|
Massachusetts | 5 | 2019 | 8662 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 704 | 0.150 |
Why?
|
United States Food and Drug Administration | 2 | 2017 | 1581 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 516 | 0.150 |
Why?
|
Pelvis | 1 | 2022 | 730 | 0.150 |
Why?
|
Learning | 1 | 2007 | 1705 | 0.150 |
Why?
|
Cystoscopes | 1 | 2016 | 5 | 0.140 |
Why?
|
Pregnancy Rate | 1 | 2020 | 643 | 0.140 |
Why?
|
Women's Health Services | 1 | 2017 | 93 | 0.140 |
Why?
|
Prospective Studies | 8 | 2021 | 53187 | 0.140 |
Why?
|
Anesthesia | 1 | 2008 | 1548 | 0.140 |
Why?
|
Pain Measurement | 4 | 2021 | 3418 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3839 | 0.140 |
Why?
|
Infertility, Female | 1 | 2022 | 784 | 0.130 |
Why?
|
Device Approval | 1 | 2017 | 163 | 0.130 |
Why?
|
Linear Models | 2 | 2019 | 5948 | 0.130 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 1392 | 0.130 |
Why?
|
Dyspareunia | 1 | 2015 | 50 | 0.130 |
Why?
|
Ovarian Neoplasms | 3 | 2017 | 4823 | 0.130 |
Why?
|
Blood Volume | 2 | 2014 | 565 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2021 | 2011 | 0.130 |
Why?
|
Peritoneal Cavity | 1 | 2014 | 148 | 0.120 |
Why?
|
Risk Factors | 9 | 2022 | 72145 | 0.120 |
Why?
|
Aged, 80 and over | 6 | 2017 | 57683 | 0.120 |
Why?
|
Nerve Block | 1 | 2021 | 640 | 0.120 |
Why?
|
Insufflation | 1 | 2014 | 65 | 0.120 |
Why?
|
Adolescent | 8 | 2023 | 85649 | 0.120 |
Why?
|
Menstrual Cycle | 1 | 2017 | 551 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 638 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2003 | 1196 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 215 | 0.120 |
Why?
|
Vaginal Discharge | 1 | 2013 | 25 | 0.120 |
Why?
|
Young Adult | 6 | 2017 | 56350 | 0.110 |
Why?
|
Outpatients | 1 | 2020 | 1483 | 0.110 |
Why?
|
Connective Tissue Cells | 1 | 2012 | 55 | 0.110 |
Why?
|
Urinary Fistula | 1 | 2012 | 41 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2015 | 357 | 0.100 |
Why?
|
Cost Allocation | 1 | 2012 | 51 | 0.100 |
Why?
|
Polyglactin 910 | 1 | 2012 | 59 | 0.100 |
Why?
|
Genes, vif | 1 | 2011 | 17 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2885 | 0.100 |
Why?
|
Genes, gag | 1 | 2011 | 61 | 0.100 |
Why?
|
Sacrum | 1 | 2013 | 289 | 0.100 |
Why?
|
Accreditation | 1 | 2014 | 449 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2012 | 718 | 0.100 |
Why?
|
Learning Curve | 1 | 2012 | 200 | 0.100 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 867 | 0.090 |
Why?
|
Pilot Projects | 3 | 2014 | 8297 | 0.090 |
Why?
|
Databases, Factual | 2 | 2017 | 7716 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9941 | 0.090 |
Why?
|
Psychomotor Performance | 1 | 2018 | 1895 | 0.090 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 24913 | 0.090 |
Why?
|
Ureter | 1 | 2012 | 374 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2011 | 166 | 0.090 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 1538 | 0.090 |
Why?
|
Inpatients | 1 | 2020 | 2495 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1585 | 0.080 |
Why?
|
New England | 1 | 2012 | 1021 | 0.080 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 497 | 0.080 |
Why?
|
Equipment Design | 2 | 2014 | 3582 | 0.080 |
Why?
|
Pregnancy Trimester, First | 2 | 2020 | 851 | 0.080 |
Why?
|
Fascia | 1 | 2009 | 135 | 0.080 |
Why?
|
Transplantation Chimera | 1 | 2011 | 612 | 0.080 |
Why?
|
Cattle | 1 | 2014 | 3923 | 0.080 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2012 | 686 | 0.080 |
Why?
|
Time Factors | 5 | 2017 | 40054 | 0.080 |
Why?
|
Research Design | 2 | 2015 | 5979 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2008 | 276 | 0.070 |
Why?
|
Patient Preference | 2 | 2015 | 886 | 0.070 |
Why?
|
Contraception | 2 | 2017 | 356 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3070 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2012 | 1679 | 0.070 |
Why?
|
Urinary Bladder | 1 | 2012 | 1171 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2017 | 2706 | 0.070 |
Why?
|
Postoperative Period | 1 | 2011 | 1839 | 0.070 |
Why?
|
Hospitals, Community | 1 | 2008 | 348 | 0.070 |
Why?
|
Lymph Node Excision | 1 | 2012 | 1248 | 0.070 |
Why?
|
Administration, Cutaneous | 1 | 2008 | 711 | 0.070 |
Why?
|
India | 1 | 2012 | 2187 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2023 | 25575 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2021 | 5062 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2013 | 12017 | 0.070 |
Why?
|
Models, Animal | 1 | 2011 | 2170 | 0.060 |
Why?
|
Incidence | 2 | 2014 | 20928 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18006 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2123 | 0.060 |
Why?
|
Administration, Topical | 1 | 2005 | 688 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2749 | 0.060 |
Why?
|
Dysmenorrhea | 1 | 2023 | 86 | 0.050 |
Why?
|
Body Mass Index | 2 | 2012 | 12695 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2924 | 0.050 |
Why?
|
Coitus | 1 | 2003 | 133 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2451 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3504 | 0.050 |
Why?
|
Registries | 1 | 2017 | 8077 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12242 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1858 | 0.050 |
Why?
|
Colposcopy | 1 | 2021 | 144 | 0.050 |
Why?
|
Collagen | 1 | 2009 | 2684 | 0.050 |
Why?
|
Logistic Models | 2 | 2015 | 13403 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3151 | 0.050 |
Why?
|
Extraction, Obstetrical | 1 | 2020 | 26 | 0.050 |
Why?
|
Parity | 1 | 2003 | 929 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35342 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2502 | 0.040 |
Why?
|
Catheterization | 1 | 2005 | 1468 | 0.040 |
Why?
|
Radiology, Interventional | 1 | 2023 | 460 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2011 | 4379 | 0.040 |
Why?
|
Pain | 2 | 2021 | 4961 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11363 | 0.040 |
Why?
|
Methotrexate | 1 | 2005 | 1720 | 0.040 |
Why?
|
Male | 7 | 2022 | 349538 | 0.040 |
Why?
|
Umbilicus | 1 | 2018 | 41 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4982 | 0.040 |
Why?
|
Animals | 4 | 2014 | 168561 | 0.040 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2021 | 482 | 0.040 |
Why?
|
Fertility | 1 | 2022 | 770 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2020 | 732 | 0.040 |
Why?
|
Ultrasonography, Prenatal | 1 | 2005 | 1694 | 0.040 |
Why?
|
Fallopian Tubes | 1 | 2017 | 182 | 0.040 |
Why?
|
Pregnancy, Unplanned | 1 | 2017 | 95 | 0.040 |
Why?
|
Macrophages | 1 | 2011 | 5655 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10472 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4554 | 0.030 |
Why?
|
Metrorrhagia | 1 | 2015 | 16 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2022 | 904 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3127 | 0.030 |
Why?
|
Triage | 1 | 2021 | 977 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3862 | 0.030 |
Why?
|
Risk Assessment | 2 | 2005 | 23320 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 660 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8621 | 0.030 |
Why?
|
Cesarean Section, Repeat | 1 | 2012 | 29 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2935 | 0.030 |
Why?
|
Propensity Score | 1 | 2019 | 1771 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2015 | 21719 | 0.030 |
Why?
|
Administration, Intravaginal | 1 | 2011 | 147 | 0.020 |
Why?
|
Electrosurgery | 1 | 2010 | 58 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2450 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2004 | 11001 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 681 | 0.020 |
Why?
|
Curriculum | 1 | 2002 | 3589 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12958 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2011 | 808 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9144 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3527 | 0.020 |
Why?
|
Cell Polarity | 1 | 2011 | 644 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2479 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1875 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1520 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2715 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1372 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14720 | 0.020 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 1004 | 0.020 |
Why?
|
HIV Infections | 1 | 2011 | 16678 | 0.020 |
Why?
|
Decision Making | 1 | 2015 | 3869 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12797 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18112 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 19223 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 12071 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81045 | 0.000 |
Why?
|